$3.2B AVAILABLE FOR R&D PROPOSALS
China renews efforts to spur innovation; HIV/AIDS a top priority
By Kristine Yang
Wednesday, March 26, 2014
HONG KONG – Over the next year, health authorities in China plan to renew their focus on biotech development and continue funding research and development of new drugs to the tune of $3.2 billion.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.